These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 19929975)

  • 1. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
    Jorgensen DM
    Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
    Marple BF; Roberts CS; de Caprariis PJ; Reisman A
    Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
    Cohen R
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
    Takker U; Dzyublyk O; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):421-9. PubMed ID: 13678479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.
    Casey JR; Pichichero ME
    Clin Infect Dis; 2005 Jun; 40(12):1748-55. PubMed ID: 15909262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis.
    Derriennic M; Voi M; Thoren LM; Black SA; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S43-6; discussion S46-8. PubMed ID: 1287618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group.
    O'Doherty B
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):718-24. PubMed ID: 8922571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin).
    Kaplan EL; Gooch III WM; Notario GF; Craft JC
    Clin Infect Dis; 2001 Jun; 32(12):1798-802. PubMed ID: 11360224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
    Norrby SR; Quinn J; Rangaraju M; Leroy B
    Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial.
    Bereznoy VV; Riley DS; Wassmer G; Heger M
    Altern Ther Health Med; 2003; 9(5):68-79. PubMed ID: 14526713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults.
    McCarty J; Hernon Y; Linn L; Therasse DG; Molina A; Bleile N
    Clin Ther; 1992; 14(1):30-40. PubMed ID: 1576624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness and tolerance of cefixime in comparison with penicillin V in bacterial pharyngitis and tonsillitis in children. Cefixime Study Group].
    Adam D; Hostalek U
    Klin Padiatr; 1994; 206(1):26-9. PubMed ID: 8152203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of azithromycin in ORL].
    Gehanno P
    Pathol Biol (Paris); 1995 Jun; 43(6):530-3. PubMed ID: 8539077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P; Dobryniewska M; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial eradication rates with shortened courses of 2nd- and 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults.
    Pichichero ME; Casey JR
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):127-30. PubMed ID: 17908614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
    J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis.
    Ehnhage A; Rautiainen M; Fang AF; Sanchez SP
    Int J Antimicrob Agents; 2008 Jun; 31(6):561-6. PubMed ID: 18456465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.